智信精密 reported revenue of ¥0.12B for the period ended 2026-06-30, +41.5% year on year. Net income was ¥-0.05B, a -45.0% net margin on a 29.9% gross margin. The largest revenue line is 自动化设备 at 40% of the total. Free cash flow for the period was ¥0.03B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.12B | +41.5% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥-0.07B | — |
| Net income | ¥-0.05B | — |
| Gross margin | 29.9% | Net margin -45.0% |
| Revenue Q/Q | +115.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 自动化设备 | ¥0.05B | 39.6% |
| 自动化线体 | ¥0.04B | 31.2% |
| 改造及技术服务 | ¥0.02B | 18.4% |
| 其他(补充) | ¥0.01B | 10.1% |
| 夹治具 | ¥0.00B | 0.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 70.1% |
| R&D | ¥0.06B | 48.6% |
| SG&A | ¥0.04B | 34.0% |
| Tax & other | ¥-0.02B | -13.4% |
| Item | Amount |
|---|---|
| Total assets | ¥1.49B |
| Total liabilities | ¥0.49B |
| Shareholders' equity | ¥1.01B |
| Equity / assets | 67.5% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.03B |
| Cash conversion (OCF / net income) | 40% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
尚水智能 ・ 港通医疗 ・ 中远通 ・ 陕西华达 ・ 长华化学 ・ 舜禹股份 ・ 万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐 ・ 福赛科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies